e6-a2 BCR-ABL1 fusion in T-cell acute lymphoblastic leukemia
e6-a2 BCR-ABL1 fusion in T-cell acute lymphoblastic leukemia
复制标题
T 细胞急性淋巴细胞白血病中的 e6-a2 BCR-ABL1 融合
DOI:
10.1038/sj.leu.2403595
复制
发表时间:
2005
期刊:
影响因子:
11.4
通讯作者:
H. Drexler
中科院分区:
文献类型:
--
作者:
H. Quentmeier;J. Cools;R. MacLeod;P. Marynen;C. Uphoff;H. Drexler
The Philadelphia chromosome (Ph) is the result of the chromosomal translocation t (9; 22)(q34; q11), leading to the BCR-ABL1 fusion gene. The Ph chromosome is the hallmark of chronic myeloid leukemia (CML), but is also detected in acute lymphoblastic leukemia (ALL), particularly in adults. The majority of Ph-positive ALL cases belong to the category of B-cell precursor ALL, whereas Ph-positive T-ALL cases are rather rare. We recently identified a novel NUP214-ABL1 fusion gene in approximately 5% of T-ALL cases and in three independent TALL cell lines, indicating that oncogenic ABL1 fusions are recurrent in T-ALL. 1 Here, we report on a T-ALL cell line expressing the e6-a2 BCR-ABL1 fusion transcript described so far only in five cases of CML. 2–6 The MHH-TALL1 cell line was established from the peripheral blood of an 11-year old boy with T-ALL in 1993. 7 Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of primary tumor cells at the time of the initial diagnosis failed to reveal the existence of a BCR-ABL1 fusion. Interestingly, however, conventional cytogenetics and fluorescence in situ hybridization performed on the cell line showed a three-way t (1; 9; 22)(q32; q34; q11) rearrangement effecting Ph formation (Figure 1). As with the patient, RT-PCR of the various conventional BCR-ABL1 fusion transcripts was negative in the cell line. However, we found a PCR product that was about 600bp larger than the e1-a2 BCR-ABL1 transcript caused by a break in the BCR minor breakpoint cluster region